You are here

Abbvie

Member Since 2018

Michael E. Severino, MD

Executive Vice President, Research & Development and Chief Scientific Officer

Dr. Severino is the Executive Vice President, Research & Development, and Chief Scientific Officer of AbbVie. He previously served as Senior Vice President, Global Development and Corporate Chief Medical Officer at Amgen Inc. Dr. Severino held other management roles at Amgen, Inc., including Vice President, Global Development and Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development. He joined AbbVie in 2014.

Abbvie

AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.